Dr. Ho is an associate professor of medicine in the Division of Hematology/Oncology, Department of Internal Medicine at Mayo Clinic, Phoenix, Arizona.
Recognizing hereditary syndromes in renal cell carcinoma
Patients may require specific diagnostic, surveillance, and therapeutic management.
How to choose systemic therapy for metastatic RCC
Combination therapy is the first-line standard for metastatic renal cell carcinoma.
2 Commerce Drive Cranbury, NJ 08512